solid pre-announce prepar covid impact
morn baxter announc result line pre-announce though
suspend outlook except amid uncertainti surround
compani seen littl impact viru date howev
monitor number factor includ increas covid-rel demand product
med deliveri may off-set weak anesthesia advanc surgeri
whole believ baxter better posit weather
period disrupt squeaki clean balanc sheet use build
inventori order suppli custom increas demand certain product
portfolio critic care product high demand diseas spread
significantli wider consequ reiter ow rate
result pre-announce morn baxter report sale
cc oper line compani januari pre-announce
previous announc med deliveri standout constant currenc
cc also outperform estim gross margin
line howev drove leverag sale admin line lead
cent ep beat compani also complet intern audit provid
restat financi statement incorpor model
guidanc pull due guid incorpor seprafilm
due outgo fluid situat involv baxter provid full year
guidanc preliminarili guid top-line growth report constant
currenc basi januari howev compani provid sale growth guidanc
constant currenc report compar street
includ seprafilm acquisit compani expect ep rang
point call surprisingli much call focus gaug
evolv situat surround manufactur standpoint
compani note experienc constraint limit number compon
manufactur china itali abl mitig note limit financi
impact compani revenu side coin baxter sever move
piec busi line med deliveri use frequent
respiratori case high demand ahead coronaviru crisi compani
make invest today build inventori ahead potenti compon
shortag also take step shore financi posit via revolv
hand advanc surgeri anesthesia tie elect procedur
may neg impact continu next page
price pressur gener competit deal execut
ebitda assum
net debt s/o
debt total capit
piper sandler seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis report read conjunct import disclosur inform
includ attest regul analyst certif found page report follow site
page
point call continu final note manag seem
warm littl valuat come back within reason level overal
lot stone overturn come week sound us like baxter
good shape weather period disrupt even benefit littl given critic
need lifesav product largest busi med deliveri pharma
stock thought like much market baxter share ytd held better
given compani strong cash flow profil clean balanc sheet rel acut
patient base regardless ultim impact situat believ name like well
equip handl even longer period disrupt name uncertain
environ consequ reiter ow rate price target move
still base ev/ebitda
page
market incom expens net net incom analysi gross market oper analysi total hospit
million
sale
market administr
revenu report
percent sale
current disclosur inform compani locat http //www pipersandl com/researchdisclosur
